AlphaReta-50

Retatrutide is a next-generation triple hormone receptor agonist acting on GLP-1, GIP, and glucagon receptors. It is widely researched for its role in metabolic regulation, insulin sensitivity, and energy expenditure.

R2 900,00

In stock

product description

Retatrutide 50mg

Retatrutide – Product Description
Retatrutide is a next-generation triple hormone receptor agonist acting on GLP-1, GIP, and glucagon receptors. It is widely researched for its role in metabolic regulation, insulin sensitivity, and energy expenditure.

Retatrutide – Research Benefits
• Supports significant body fat reduction in metabolic research models
• Improves glucose handling and insulin sensitivity
• Enhances energy expenditure and metabolic efficiency
• Reduces visceral adiposity

These products are sold strictly for laboratory research purposes only. They are not intended for human consumption, medical treatment, diagnosis, or prevention of disease. Alpha Blueprint Peptides makes no therapeutic claims. Buyers are responsible for compliance with South African laws, customs regulations, and research ethics.

Medical References
Triple–Hormone-Receptor Agonist Retatrutide for Obesity (NEJM, 2023)

PubMed: https://pubmed.ncbi.nlm.nih.gov/37366315/

Journal: https://www.nejm.org/doi/10.1056/NEJMoa2301972

product reviews

Reviews

There are no reviews yet.

Be the first to review “AlphaReta-50”

Your email address will not be published. Required fields are marked *

IMPORTANT DISCLAIMER:
Content on this website is for informational purposes only and does not constitute medical advice. Products are sold for research purposes only and are not intended for human or animal use.
Consult a registered healthcare professional before making health-related decisions.

Nationwide delivery

We ship nationwide with reliable couriers directly to your door.

Research Backed

We offer a research-backed selection of high-quality Peptides.

Secure payments

Payments are processed by a trusted online payment provider.